OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

Clinical trial NCT07136012 · RECRUITING

Trial details

NCT number: NCT07136012
Sponsor: Amgen
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiovascular Disease

Start date: 2025-08-22
Primary completion: 2031-10-20
Enrollment: 11000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.